Apyx Medical Corporation
Apyx Medical Corporation (APYX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · APYX · as of Sep 30, 2025
Ownership Breakdown
50
Institutional Holders
▲ 9 vs Q2
$33.67M
Total Inst. Value
▼ $1.90M vs Q2
41.87M
Shares Outstanding
freeFloat 86.73%
15.74M
13F Shares Held
▼ 74,064 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
APYX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
NANTAHALA CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 3.34M | 8.20% | 8.20% | $7.14B | Nov 14, 2025 | — held |
ARCHON CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 3.28M | 8.06% | 8.06% | $7.02B | Nov 14, 2025 | — held |
ROYCE & ASSOCIATES LP surgical & medical instruments & apparatus | 2.47M | 6.08% | 6.08% | $5.30B | Nov 12, 2025 | ▲ 34.7K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.53M | 3.75% | 3.75% | $3.27B | Nov 7, 2025 | ▲ 53.2K |
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 986.5K | 2.42% | 2.42% | $2.11B | Oct 7, 2025 | ▲ 89.8K |
COMMONWEALTH EQUITY SERVICES, LLC surgical & medical instruments & apparatus | 663.5K | 1.63% | 1.63% | $1.42B | Oct 22, 2025 | — held |
HORIZON KINETICS ASSET MANAGEMENT LLC surgical & medical instruments & apparatus | 615.0K | 1.51% | 1.51% | $1.32B | Nov 14, 2025 | — held |
BLACKROCK, INC. surgical & medical instruments & apparatus | 509.8K | 1.25% | 1.25% | $1.09B | Nov 12, 2025 | ▲ 6.8K |
TAYLOR FRIGON CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 470.7K | 1.16% | 1.16% | $1.01B | Oct 21, 2025 | ▼ 8.3K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 351.3K | 86.25% | 86.25% | $751.92M | Nov 12, 2025 | ▲ 1.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
14
Increased
+310.2K shares10
New Positions
first time holders9
Decreased
−456.4K shares0
Sold Out
fully exitedNet shares change (top 50)
146.2K
+310.2K / −456.4K
Net new holders
+15
10 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
APYX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
2
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
HILL MATTHEW C Chief Financial Officer | May 15, 2025 | Award | 100,000 | $1.48 | $148.0K | 100.0K | Form 4 ↗ |
CITRONOWICZ MOSHE Sr. V.P. of Operations | May 15, 2025 | Award | 36,000 | $1.48 | $53.3K | 36.0K | Form 4 ↗ |
Waldman Lawrence director | May 15, 2025 | Award | 30,000 | $1.48 | $44.4K | 30.0K | Form 4 ↗ |
Baylor-Henry Minnie director | May 15, 2025 | Award | 59,000 | $1.48 | $87.3K | 59.0K | Form 4 ↗ |
Vizirgianakis Stavros G. director | May 15, 2025 | Award | 128,000 | $1.48 | $189.4K | 128.0K | Form 4 ↗ |
Goodwin Charles D. II Chief Executive Officer | May 15, 2025 | Award | 193,000 | $1.48 | $285.6K | 193.0K | Form 4 ↗ |
Levine Wendy Lauren director | May 15, 2025 | Award | 64,000 | $1.48 | $94.7K | 64.0K | Form 4 ↗ |
HILL MATTHEW C Chief Financial Officer | Aug 13, 2024 | Purchase | 6,000 | $1.13 | $6.8K | 8.5K | Form 4 ↗ |
Roman Shawn David Chief Operating Officer | Jan 15, 2025 | Award | 100,000 | $1.42 | $142.0K | 100.0K | Form 4 ↗ |
Goodwin Charles D. II Chief Executive Officer | Jan 15, 2025 | Award | 50,000 | $1.42 | $71.0K | 50.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Apyx Medical Corporation (APYX) is primarily owned by institutional investors, who hold approximately 37.6% of total shares outstanding. Company insiders own approximately 13.27%, while retail and public investors account for the remaining 49.15%.
The largest institutional shareholder of Apyx Medical Corporation is NANTAHALA CAPITAL MANAGEMENT, LLC, holding approximately 3.34 million shares — equal to 8.20% of outstanding shares — as of September 30, 2025.
A total of 50 institutional investors currently hold APYX stock, with a combined institutional value of approximately $33,674,427 as of the most recent 13F filing period.
Frequently asked questions
APYX ownershipApyx Medical Corporation (APYX) is primarily owned by institutional investors, who hold approximately 37.6% of shares. The largest shareholder is NANTAHALA CAPITAL MANAGEMENT, LLC with a 8.20% stake. Company insiders hold 13.27%. Data sourced from SEC Form 13F as of September 30, 2025.